NIFTY 50

Q1FY22 earnings preview: Here’s what to expect from diagnostic companies

Updated : July 16, 2021 09:47:28 IST

Diagnostic companies are expected to be aided by a surge in COVID-19 testing, as well as a favourable base.

COVID-19 testing, for example, rose from 1,500 to 2,000 tests per day to around 10,000-12,000 tests per day at its peak during the second wave.

Dr Lal PathLabs is estimated to grow around 70 percent year on year (YoY) and 4-5 percent quarter on quarter (QoQ) led by COVID-19 and allied testing, which would probably show up to 11 percent YoY growth. Non-COVID-19 testing should be aided by a favourable base as well.

Watch the accompanying video of CNBC-TV18’s Ekta Batra for more details.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you